Engineering of an EpCAM-targeting cyclic peptide to improve the EpCAM-mediated cellular internalization and tumor accumulation of a peptide-fused antibody
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineering of an EpCAM-targeting cyclic peptide to improve the EpCAM-mediated cellular internalization and tumor accumulation of a peptide-fused antibody
Authors
Keywords
Cyclic peptide, EpCAM, Cytosol-penetrating antibody, Peptide-antibody fusion, Affinity maturation, Tumor homing
Journal
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Volume 573, Issue -, Pages 35-41
Publisher
Elsevier BV
Online
2021-08-08
DOI
10.1016/j.bbrc.2021.08.021
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity
- (2021) Jung-Eun Kim et al. Frontiers in Immunology
- Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01
- (2021) Se-Young Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape
- (2021) Ji Eun Lee et al. CANCER LETTERS
- Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant–driven tumor growth
- (2020) Seung-Min Shin et al. Science Advances
- Targeting Strategies for Tissue-Specific Drug Delivery
- (2020) Zongmin Zhao et al. CELL
- A neuropilin-1 antagonist exerts anti-tumor immunity by inhibiting the suppressive function of intratumoral regulatory T cells
- (2019) Keunok Jung et al. Cancer Immunology Research
- Dual-targeting of EGFR and Neuropilin-1 attenuates resistance to EGFR-targeted antibody therapy in KRAS-mutant non-small cell lung cancer
- (2019) Ye-Jin Kim et al. CANCER LETTERS
- Engineering of a tumor cell–specific, cytosol-penetrating antibody with high endosomal escape efficacy
- (2018) Ji-sun Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- High Affinity Promotes Internalization of Engineered Antibodies Targeting FGFR1
- (2018) Łukasz Opaliński et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Peptide-based targeted therapeutics: Focus on cancer treatment
- (2018) Fatemeh Araste et al. JOURNAL OF CONTROLLED RELEASE
- Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment
- (2018) Matthieu Chodorge et al. Scientific Reports
- Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability
- (2017) Du-San Baek et al. MOLECULAR PHARMACEUTICS
- Biophysical properties of the clinical-stage antibody landscape
- (2017) Tushar Jain et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration
- (2017) Seung-Min Shin et al. Nature Communications
- Endosomal acidic pH-induced conformational changes of a cytosol-penetrating antibody mediate endosomal escape
- (2016) Ji-Sun Kim et al. JOURNAL OF CONTROLLED RELEASE
- A novel screening method to assess developability of antibody-like molecules
- (2015) Neeraj Kohli et al. mAbs
- A general strategy for generating intact, full-length IgG antibodies that penetrate into the cytosol of living cells
- (2014) Dong-Ki Choi et al. mAbs
- Epithelial cell adhesion molecule-targeted drug delivery for cancer therapy
- (2013) Manuel Simon et al. Expert Opinion on Drug Delivery
- Monoclonal antibody therapeutics with up to five specificities: Functional enhancement through fusion of target-specific peptides
- (2013) David LaFleur et al. mAbs
- Pyroglutamate andO-Linked Glycan Determine Functional Production of Anti-IL17A and Anti-IL22 Peptide-Antibody Bispecific Genetic Fusions
- (2012) Xiaotian Zhong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors
- (2011) S. I. Rudnick et al. CANCER RESEARCH
- A Novel Fusion Toxin Derived from an EpCAM-Specific Designed Ankyrin Repeat Protein Has Potent Antitumor Activity
- (2010) P. Martin-Killias et al. CLINICAL CANCER RESEARCH
- The functional capacity of the natural amino acids for molecular recognition
- (2010) Sara Birtalan et al. Molecular BioSystems
- EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins
- (2009) J. Winkler et al. MOLECULAR CANCER THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started